CRYO-CELL INTERNATIONAL, INC. (OTCMKTS:CCEL) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

CRYO-CELL INTERNATIONAL, INC. (OTCMKTS:CCEL) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders

On July18, 2017, Cryo-Cell International, Inc. (the “Company”) held its Annual Meeting of Stockholders.At the Annual Meeting, shareholders considered the election of five directors, the ratification of independent registered public accountants and the approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers in its proxy statement for shareholder consideration.

The final result of the stockholder vote was certified on July18, 2017 and is as follows:

1. To consider for election five individuals to the Company’s Board of Directors

Under plurality voting, the five nominees who received the most “FOR” votes were elected as directors.The Company’s stockholders elected the Board of Director’s five nominees: Harold Berger; David Portnoy; Mark Portnoy; George Gaines; and Jonathan Wheeler, M.D. as directors, each for a one-year term, as follows:

Harold Berger

For

 3,357,798

Withhold

 76,043

Brokernon-votes

 3,151,110

George Gaines

For

 3,402,648

Withhold

 31,193

Brokernon-votes

 3,151,110

David I. Portnoy

For

 3,380,451

Withhold

 53,390

Brokernon-votes

 3,151,110

Mark L. Portnoy

For

 3,370,588

Withhold

 63,253

Brokernon-votes

 3,151,110

Jonathan H. Wheeler, M.D.

For

 3,392,648

Withhold

 41,193

Brokernon-votes

 3,151,110
2. The ratification of the appointment of Porter Keadle Moore LLC as the Company’s independent registered public accounting firm for the fiscal year ending November30, 2017.

For

Against

Abstain

Broker Non-Vote

6,584,951

 12,507 3,474 —
3. The approval of the Company’s non-binding resolution regarding the compensation of the Company’s named executive officers.

For

Against

Abstain

Broker Non-Vote

3,250,943

 177,132 5,766 3,151,110


About CRYO-CELL INTERNATIONAL, INC. (OTCMKTS:CCEL)

Cryo-Cell International, Inc. is engaged in cellular processing and cryogenic storage. The Company’s segments include cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacture of Prepacyte CB units, the processing technology used to process umbilical cord blood stem cells. The Company, in combination with its global affiliates, stores over 300,000 cord blood and cord tissue specimens around the world. The specimens are stored in commercially available cryogenic storage units at the facility in Oldsmar, Florida. The Company offers the cord tissue service in combination with the umbilical cord blood service. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals.